SCHEMBL24530280

SCHEMBL24530280

N#CCN(CC#N)CCNCCN1CCN(CCN(CC#N)CCN)C1=O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.32
DPP4 P27487 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24530379 0.97 ACE2 (0.32) ACE2DPP4
SCHEMBL24530367 0.94 ACE2 (0.36) ACE2DPP4
SCHEMBL24530413 0.93 DPP4 (0.31) DPP4
SCHEMBL24530306 0.92 DPP4 (0.33) DPP4
SCHEMBL24530356 0.92 DPP4 (0.34) DPP4
SCHEMBL24530438 0.91 ACE2 (0.34) ACE2DPP4
SCHEMBL24530296 0.91 ACE2 (0.36) ACE2DPP4
SCHEMBL24530419 0.91 ACE2 (0.34) ACE2DPP4
SCHEMBL24530370 0.91 ACE2 (0.41) ACE2DPP4
SCHEMBL24530261 0.91 ACE2 (0.38) ACE2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263507-B1 MANUFACTURE OF NITRILE COMPOUNDS NOURYON CHEMICALS INT BV (NL) 2025-02-05 EP disclosed
US-20240132444-A1 MANUFACTURE OF NITRILE COMPOUNDS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2024-04-25 US disclosed
WO-2022129020-A1 MANUFACTURE OF NITRILE COMPOUNDS NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132444-A1 MANUFACTURE OF NITRILE COMPOUNDS NCLN, NCL, HNMT ACE2 2873/4885DPP4 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.